Introduction
============

Lung cancer is the most common cancer by incidence (1.82 million in 2012) and a leading cause of cancer-related deaths (1.6 million deaths in 2012) worldwide [@B1]. Most lung cancer patients are diagnosed at an advanced stage, and hence are not able to undergo surgical removal of tumors[@B2]. Systemic chemotherapy and radiotherapy are currently the main treatment options for lung cancer, but most patients eventually develop resistance to these treatments. As a result, the overall 5-year survival rate for lung cancer patients is still low [@B3]. Since early stage detection is essential for effective therapy, it would be important to develop an accurate lung cancer risk forecasting model that could identify individuals at high-risk.

Several models[@B4]-[@B7] have been developed to predict individual risk for lung cancer within a specified period by using a patient\'s characteristics, epidemiologic, social, and clinical risk factors, including age, body mass index (BMI), socioeconomic status, cigarette smoking history, second-hand smoke exposure in never-smokers, asbestos exposure, chronic obstructive pulmonary disease (COPD) history, pneumonia history, and a family history of lung cancer. Other factors associated with lung cancer in epidemiological studies might also be useful for forecasting, including dietary factors[@B8], exposure to cooking emissions[@B9], and occupational exposure to diesel or gasoline[@B10], pesticides[@B11], and ink[@B12].

Recent advances in genetic epidemiology have led to identification of genetic and molecular variants affecting the risk of diseases, suggesting that genetic markers, such as single-nucleotide polymorphisms (SNP), can be added to risk models to improve forecasting of future risk of disease[@B7],[@B13]. Genome-wide association studies (GWAS) and large case-control studies have identified a considerable number of genetic susceptibility loci associated with lung cancer risk[@B14]-[@B24], including telomerase reverse transcriptase (*TERT*).

*TERT* is a reverse transcriptase that is critical for telomere replication and stabilization by controlling telomere length. The telomerase enzyme protein is highly expressed in many tumor tissues, including lung cancer, whereas it is tightly repressed in most normal human cells [@B25]-[@B26]. High TERT expression predicts poor prognosis in patients with lung cancer[@B27]. When*TERT*is inhibited, cancer cells undergo telomere shortening, senescence or apoptosis, and eventually lose their oncogenic potential. However, the exact role of rs2736100 in the pathogenesis of lung cancer remains to be defined.

Nearly all of the published models have focused on either genetic variables (e.g. SNPs) or epidemiological variables. Lung cancer is a multi-etiological disease initiated by both genetic and lifestyle factors. Thus, in this study we attempted to establish an ethnicity-specific lung cancer risk forecasting model by combining gene polymorphisms, like *TERT* rs2736100, with epidemiologic factors, aiming to provide a more precise prediction in a Chinese population.

Materials and Methods
=====================

Study population
----------------

This study was a hospital-based case-control study involving a total of 1000 subjects from northeastern China (Changchun, Jilin Province). All subjects were local residents of Han descent, comprising 500 lung cancer patients and 500 cancer-free controls. Eligible patients had histologically confirmed primary lung cancer without previous cancer history and with no radiotherapy or chemotherapy for other conditions. Control participants were randomly selected from individuals receiving routine physical examinations in our hospital. The selection of controls was frequency-matched to cases by age, gender, and residential area (urban or rural). The study was approved by the Ethics Committee of the First Hospital of Jilin Medical University, and conducted according to Declaration of Helsinki principles. All subjects signed a written informed consent at the beginning of the study.

Data collection
---------------

Standard interviews were conducted by trained physicians at either the hospital or the participants\' homes. A standardized lifestyle questionnaire was used to collect socioeconomic status, medical history, family history, lifestyle history, and cancer diagnosis. Risk factor information and peripheral blood lymphocytes were collected prior to and up to the time of diagnosis for cancer patients and at the interview date for control subjects.

According to the Chinese food pagoda [@B28], the recommended daily intake levels are 300-500 g for vegetables, 200-400 g for fruits, 50-75 g for meats, 50-100 g for fish and shrimp, 30-50 g for soybean products and nuts, and 300 g for dairy. Based on these recommended levels, we divided the amounts of meat, soybean products and nuts, and dairy products into three (inadequate, normal, and excess) or two (inadequate and adequate) levels, respectively, which were used as inputs for model development. For vegetable consumption, fruits, fish and shrimp, amounts of daily intakes were entered into the model directly. Since there were limited data on the exposure to asbestos and recent chest x-rays in either cases or controls, these items were excluded from analysis.

Genotyping and quality control
------------------------------

DNA was extracted from the peripheral blood lymphocytes using a Wizard® Genomic DNA Purification Kit A1125 (Promega, WI, USA). MassArray (Sequenom, CA, USA) was employed for genotyping all markers by using allele specific matrix-assisted laser desorption/ionization time-of-flight mass spectrometry[@B29] according to the manufacturer\'s instructions. Primers and multiplex reactions were designed by using the RealSNP.com Website.

All lung cancer patients as well as healthy controls were genotyped for *TP6*rs4488809, *TERT*rs2736100, *MIPEP-TNFRSF19*rs753955, *MTMR3-HORMAD2-LIF*rs17728461, *CHRNA3*rs6495309, and *WWOX*rs3764340 polymorphisms. These SNPs have been reported previously in association with lung cancer risk by GWAS analyses in case-control studies[@B20]-[@B24]. Concordance among the three genomic control DNA samples presented in duplicate was 100%. Of SNPs with genotyping data, call rates were \>95%.

Statistical analysis
--------------------

Hardy-Weinberg equilibrium was tested by a goodness-of-fit chi-square (χ^2^) test. The χ^2^ test was used to determine genotype frequencies with observed genotype frequencies in cancer-free controls vs lung cancer cases and association of SNP with clinicopathological data. Multiple logistic regression model was performed to identify independent risk factors for lung cancer. A forward stepwise likelihood ratio method was employed to screen variables in the model selection, where the cut-off for variables in the model was 0.05 and the cut-off for variables out of model was 0.10. We selected the optimal model with the maximum Cox & Snell R square and Nagelkerke R square. All categorical variables were set as dummy variables, and the first category of each variable was selected as baseline. All analyses were conducted by SPSS v19.0 software (SPSS, Inc., Chicago, IL, USA). All *p*-values were two-sided, and those \<0.05 were considered statistically significant. Multiplicative models were used for rs4488809, rs2736100, rs753955, rs3764340, and rs17728461 in the multiple logistic regression model. The classification ability of the model was evaluated using the area under the receiver operating characteristic (ROC) curve (AUC).

Results
=======

Characteristics, genotypes and risk factors of participants
-----------------------------------------------------------

A total of 500 lung cancer patients and 500 controls were recruited between 2010 and 2012. **Tables [1](#T1){ref-type="table"}-[2](#T2){ref-type="table"}**shows the distribution of study-specific risk factors and the genotype distributions of SNPs between cases and controls. We focused on six SNPs that were reported previously in association with lung cancer [@B21]-[@B24],[@B28], including *TP63*rs4488809, *TERT*rs2736100, *MIPEP-TNFRSF19*rs753955, *MTMR3-HORMAD2-LIF*rs17728461, *CHRNA3*rs6495309, and *WWOX*rs3764340. All SNPs followed Hardy-Weinberg equilibrium in the control groups (*P*\>0.05).

Association between SNPs and lung cancer risk by univariate analysis
--------------------------------------------------------------------

No significant differences of SNPs between the lung cancer group and the healthy control group were found in five SNPs, including rs4488809, rs753955, rs6495309, rs3764340, and rs17728461 (**Table [2](#T2){ref-type="table"}**). However, the C allele of *TERT*rs2736100 was significantly associated with the increased risk of lung cancer (*p*=0.000).

Multivariate logistic regression model
--------------------------------------

Multivariate logistic repression analysis was then performed to select risk factors and SNPs for the prediction model. A forward stepwise likelihood ratio method was employed to screen variables in the regression model. The final optimal model was selected by including a total of 12 risk factors, with the maximum Cox & Snell R square (0.43) and Nagelkerke R square (0.57) **(Table [3](#T3){ref-type="table"}**). In addition to *TERT*rs2736100, the *WWOX*rs3764340 genotype was also significantly included in the model in combination with other epidemiological factors.

The fitted final multivariate logistic regression model is presented in **Table [4](#T4){ref-type="table"}**. Significantly increased lung cancer risk in the multivariate analysis was found to be associated with the following factors: lower education, lower BMI, COPD history, heavy cigarettes smoking, heavy cooking emission, and dietary factors, including deficient in fish/shrimp, vegetables, dairy products, soybean products and nuts, and over-sufficient meat. *TERT*rs2736100 was still significantly associated with a high-risk of lung cancer even after adjusting for confounding factors. For the gene-gene and gene-environment interaction analyses, only the WWOX rs3764340 genotype was correlated with the TERT rs2736100 genotype (p\<0.05) and cooking emissions (p\<0.01).

ROC analysis
------------

**Figure [1](#F1){ref-type="fig"}**shows the ROC curve derived from our model with or without SNP variables, respectively. The ROC AUC of the model was 0.89 with SNPs and was 0.88 without SNPs, respectively.

Discussion
==========

In this study, we found that education, BMI, prior diagnosis of COPD, occupational exposure to pesticide, duration of smoking, exposure to heavy cooking emissions, and dietary factors, which included less fish and shrimp, vegetable, soybean products and nuts, and more meat, were all associated with the development of lung cancer. Most importantly, we discovered that, when incorporated with environmental and lifestyle factors, *TERT*rs2736100 and *WWO*X rs3764340 were significantly associated with lung cancer.

By using patients\' characteristics and epidemiologic, social, and clinical risk factors, several lung cancer risk forecasting models [@B4]-[@B6] have been proposed, but most predictors focused on traditional risk factors, such as age, gender, smoking status, education level, BMI, lung cancer family history, environmental exposure, pneumonia history, and COPD history. The model of Bach *et al*[@B4] was developed to determine variation in lung cancer risk among either current or former smokers aged between 55 and 74 years, who were enrolled in a clinical trial for lung cancer prevention. Since this model was developed by using data from individuals with smoking history, it is only applicable to a subset of smokers who are at risk for lung cancer. The initial model by Spitz *et al*[@B30] was cross-validated using c statistics (a measure of the discriminative power of the logistic equation) of 0.59, 0.63, and 0.65 in never, former, and current smokers, respectively. It was then improved by adding two markers of DNA repair capacity, which increased the ROC AUC from 0.67 to 0.70 in former smokers and from 0.68 to 0.73 in current smokers[@B31]. However, this model requires technical expertise and is not readily available in general practice. Cassidy *et al*[@B32] described a lung cancer risk forecasting model, which had an internally validated (cross-validation) ROC AUC of 0.70. By combining patients\' socio demographic and clinical records, Iyen-Omofoman *et al* [@B33] developed a lung cancer risk forecasting model, which can be used by general practitioners to aid earlier identification of high-risk patients for lung cancer. The Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial) model [@B5] was developed to determine variation in lung cancer risk among either the general population or ever-smokers; it reported a bootstrap optimism-corrected ROC AUC of 0.857 for the first group and 0.805 for the second group.

In contrast to these traditional risk factors, SNPs are inherited genetic variations that occur during the lifetime of an individual. Inclusion of SNPs may improve the predictive ability of lung cancer risk models. Indeed, the predictive ability of our model was significantly improved by adding SNPs. For example, the ROC AUC of the model with SNP and without SNP was 0.89 and 0.88, respectively. Similarly, by adding a marker SNP (rs663048) in *SEZ6L*gene, the Liverpool Lung Project risk model did improve the forecasting capability of lung cancer [@B32],[@B34].

Recently, GWAS studies have identified three susceptibility loci for lung cancer, including the 15q24-25.1 (*CHRNA3-5*genes) [@B14]-[@B16], [@B19], 5p15.33 (*TERT-CLPTM1L*genes) [@B17]-[@B19], and 6p21.33 (*BAT3-MSH5*genes) [@B19] in European population. In addition, several susceptibility SNPs for lung cancer in the Asian population were also identified. In a GWAS aimed at identifying lung adenocarcinoma susceptibility-related genes, Miki *et al*.[@B20] found that the *TERT*rs2736100, and *TP63*rs10937405 and rs4488809 were significantly associated with lung adenocarcinoma in Japanese and Korean populations. In another GWAS of lung cancer performed in a Chinese population, Hu *et al.*[@B21] identified 6 well-replicated SNPs with independent effects and significant lung cancer associations. These SNPs are located in *TP63*(rs4488809 at 3q28), *TERT-CLPTM1L*(rs465498 and rs2736100 at 5p15.33), *MIPEP-TNFRSF19*(rs753955 at 13q12.12), and *MTMR3-HORMAD2-LIF*(rs17728461 and rs36600 at 22q12.2). Moreover, Wu *et al.*[@B24] conducted two-stage case-control studies in subjects derived from both Northern and Southern China, and identified 4 novel SNPs (rs2036534 C/T, rs667282 C/T, rs12910984 G/A, and rs6495309 T/C), which were significantly associated with increased lung cancer risk and smoking behavior. In addition, a two-stage case-control study in subjects from Southern and Eastern China showed that 2 tag SNPs (rs3764340 C/G and rs383362 G/T), located in the *WWOX*gene, were significantly associated with lung cancer risk [@B23].

Lung cancer is a polygenic disease, for which many genetic factors including SNPs appear to play an important role in disease development. But lung cancer risk prediction model include only SNPs from GWAS is not sufficient. Huan Li*et al* [@B35] developed a lung cancer risk forecasting model, five single-nucleotide polymorphisms (SNPs) identified in previous GWA or large cohort studies were genotyped in 5068 Chinese case-control subjects. The weighted genetic risk score (wGRS) based on these SNPs was estimated, and the AUC value of it was 0.551. When incorporated with Smoking history, the AUC value increased to 0.639 (0.621-0.652) after adjustment for over-fitting. Which indicate that future studies should focus on establishing a risk assessment model that incorporates both genetic variants and established traditional factors for lung cancer.

Based on these recent findings, we have developed a novel lung cancer risk forecasting model for the Chinese population by incorporating SNPs with environmental and lifestyle factors. We took advantage of a hypothesis-driven candidate gene approach [@B15],[@B36],[@B37] to identify potentially functional SNPs associated with histologically validated lung cancer. In contrast to genome-wide association (GWA) and quantitative trait locus (QTL) approaches, the candidate gene approach is economical and has rather high statistical power[@B15]. Previous studies have suggested that there may be a significant difference in lung cancer susceptibility loci between European and Asian populations. Thus, we selected SNPs identified by GWASs and large scale studies which showed an association with lung cancer risk in the population of Asia. As we just describe that environmental and lifestyle factors are very important during the development of cancers. The AUC of model only include SNPs is about 0.551[@B35]. However, the effects of SNPs were always weakened or dismissed when incorporated with several environmental and lifestyle factors. When analyzing the effects of genetic factors, such as SNPs, very few forecasting models of lung cancer included as many environmental and lifestyle factors as did in our model. We found that *TERT*rs2736100 was still significantly associated with lung cancer when incorporated with many environmental and lifestyle factors. Overall, our data were consist with those from meta-analyses[@B38]-[@B40], thus providing evidence that this locus is strongly associated with the development of the disease.

The specific function of *TERT*rs2736100 in lung cancer is largely unknown. Multiple GWAS studies have suggested its association with leukocyte telomere length (LTL) in different populations[@B41]-[@B43]. However, the specific mechanism driving the association between rs2736100 C and longer telomeres remains to be determined. A previous bioinformatics analysis suggests that this polymorphism may be located in a regulatory region of the TERT gene[@B44]. As compared to the A allele, the C allele of rs2736100 was significantly associated with increased *TERT* mRNA expression in both normal and lung cancer cells[@B45]. Future studies are needed to address how the C allele sequence has a significantly higher capacity for enhancing *TERT*transcription.

It is also interesting to note that over-sufficient meat consumption was strongly associated with lung cancer risk, even after adjusted for the other confounding factors (**Table [4](#T4){ref-type="table"}**). It is suspected that meat processing, like preservation, cooking and/or processed methods, may increase the exposure to mutagens and carcinogens, such as N-Nitroso compounds, heterocyclic amines and polycyclic aromatic hydrocarbons. Further studies are needed to examine the involvement of these factors in the lung cancer prediction model.

This study had several limitations. First, we could not include all SNPs that were identified in the Chinese population or other Asian countries populations. Additional susceptibility loci for lung cancer remain to be discovered. It is possible that rare variants with high penetrance would explain the remaining heritability. Combining these remaining SNPs would result in an ethnicity-specific classification of lung cancer risk. Second, our assessment model was an internal validation, and thus external validation needs to be performed in future studies. We will continue to recruit study subjects in this ongoing project. With the increment in statistic power, we will be able to validate our risk models using different approaches, including the integrated discrimination improvement index or change in c statistics. Thirdly, this study is retrospective. Our data provided evidence that lung cancer is associated with the education, BMI, prior diagnosis of COPD, occupational exposure to pesticide, duration of smoking, exposure to heavy cooking emission, less fish and shrimp, vegetable, soybean products and nuts. Meat consumption was not convincing, probably due to relatively small sample size. It cannot be excluded that some of the findings, although statistically significant, are probably owing to type 1 error. Thus, they need to be validated by a large-scale prospective study. Fourthly, in the screening of the model, we include the patients with family history, which might lead to bias. So a future study will be needed to include more subjects so that patients who have family history will be excluded from the analysis or appropriately be adjusted in the modeling. Finally, the association between lung cancer and *WWO*X rs3764340 was statistically significant in the multivariate logistic regression model (**Tables [3](#T3){ref-type="table"}-[4](#T4){ref-type="table"}**), but not in the univariate analysis (**Table [2](#T2){ref-type="table"}**). A further interaction analysis with other factors involved in the model showed that *WWO*X rs3764340 was also related to *TERT* rs2736100 (p=0.017) and cooking emissions (p=0.008). The Spearman\'s correlation coefficient was not 0. Thus, Future studies are needed to address the role of the gene-gene or gene-environment interaction in this prediction model.

In conclusion, our lung cancer risk forecasting model has demonstrated high discrimination capability to distinguish between high- and low-risk individuals. Most importantly, our study discovered that *TERT*rs2736100 and *WWOX*rs3764340 are associated with lung cancer risk when combined with environmental and lifestyle factors. Future large cohort studies are needed to validate this model in Chinese populations. The final lung cancer risk forecasting model will be used to discriminate individuals with high risk of developing lung cancer
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###### 

Characteristic in case and healthy control groups and the associated distribution of risk factors.

  Characteristic                         Case group (n=500)            Control group (n=500)   P-value       
  -------------------------------------- ----------------------------- ----------------------- ------------- --
  Gender                                 Male                          305 (61.0%)             302 (60.4%)   
  Female                                 195 (39.0%)                   198 (39.6%)             0.85          
  Age (years)                            \<30                          2 (0.4%)                5 (1.0%)      
  30-39                                  14 (2.8%)                     16 (3.2%)                             
  40-49                                  64 (12.8%)                    70 (14.0%)                            
  50-59                                  176 (35.2%)                   196 (39.2%)                           
  60-69                                  174 (34.8%)                   148 (19.7%)                           
  ≥70                                    70 (14.0%)                    65 (13.0%)              0.42          
  Education                              Junior high school or lower   318 (63.6%)             130 (26.0%)   
  High school                            97 (19.4%)                    144 (28.8%)                           
  Greater than high school               85 (17.0%)                    226 (45.2%)             0.00          
  Smoking (pack-years)                   14.25 (0.0-36.0)              0.00 (0.0-6.9)          0.00          
  Fish and shrimps (g/day)               4.00 (2.5-17.1)               14.29 (3.3-28.6)        0.00          
  Vegetable (g/day)                      177.10 (148.3-199.2)          205.60 (174.8-407.9)    0.00          
  Fruit (g/day)                          60.70 (31.40-101.90)          99.50 (49.80-201.30)    0.00          
  Meat                                   Deficient                     296 (59.2%)             304 (60.8%)   
  Normal                                 108 (21.6%)                   128 (25.6%)                           
  Over-sufficient                        96 (19.2%)                    68 (13.6%)              0.04          
  Dairy products                         Deficient                     499 (99.8%)             457 (91.4%)   
  Sufficient                             1 (0.2%)                      43 (8.6%)               0.00          
  Soybean products and nuts              deficient                     327 (65.4%)             228 (45.6%)   
  Normal                                 93 (18.6%)                    80 (16.0%)                            
  Over-sufficient                        80 (16.0%)                    192 (38.4%)             0.00          
  Alcohol (times/week)                   0                             276 (55.2%)             297 (59.4%)   
  1-2                                    104 (20.8%)                   130 (26.0%)                           
  3-6                                    31 (6.2%)                     43 (8.6%)                             
  ≥7                                     89 (17.8%)                    30 (6.0%)               0.00          
  Exposure to pesticide                  Absent                        398 (79.6%)             473 (94.6%)   
  Present                                102 (20.4%)                   27 (5.4%)               0.00          
  Exposure to gasoline/diesel            Absent                        487 (97.4%)             496 (99.2%)   
  Present                                13 (2.6%)                     4 (0.8%)                0.04          
  Cooking emissions (total dish-years)   Absent                        244 (48.8%)             250 (50.0%)   
  ≤50                                    149 (29.8%)                   152 (30.4%)                           
  51-100                                 61 (12.2%)                    80 (16.0%)                            
  101-150                                46 (9.2%)                     18 (3.6%)               0.00          
  Pneumonia history                      Absent                        477 (95.4%)             490 (98.0%)   
  Present                                23 (4.6%)                     10 (2.0%)                             
  COPD history                           Absent                        449 (89.8%)             489 (97.8%)   
  Present                                51 (10.2%)                    11 (2.2%)               0.00          
  Pulmonary tuberculosis history         Absent                        470 (94.0%)             486 (97.2%)   
  Present                                30 (6.0%)                     14 (2.8%)               0.02          
  Bronchial asthma history               Absent                        488 (97.6%)             495 (99.0%)   
  Present                                12 (2.4%)                     5 (1.0%)                0.10          
  Cancer family history                  Absent                        330 (66.0%)             397 (79.4%)   
  Present                                170 (34.0%)                   103 (20.6%)             0.00          
  BMI (kg/m^2^)                          \<18.5                        49 (9.8%)               15 (3.0%)     
  18.5-24                                302 (60.4%)                   230 (46.0%)                           
  ≥24                                    149 (29.8%)                   255 (51.0%)             0.00          
  Histology types                        Squamous cell                 141(28.2%)                            
  Adenocarcinomas                        176(35.2%)                                                          
  Small cell                             126(25.2%)                                                          
  Other carcinomas\*                     57(11.4%)                                                           

###### 

Genotype of SNPs in case and healthy control groups and the association of SNPs with lung cancer risk in univariate analysis.

  SNP^(Reference)^              Genotype   Case   Control   Crude OR (95% CI)   *P*-value                      
  ----------------------------- ---------- ------ --------- ------------------- ----------- ------------------ ------
  rs4488809^(21,22)^            CC         133    26.6      140                 28.0                           
  3q28,*TP63*                   CT         252    50.4      258                 51.6                           
                                TT         115    23.0      102                 20.4                           
  Multiplicative model          C vs T                                                      0.92(0.77-1.10)    0.37
  rs2736100^(22,23)^            CC         112    22.4      80                  16.0                           
  5p15.33,*TERT*                CA         257    51.4      242                 48.4                           
                                AA         131    26.2      178                 35.6                           
  Multiplicative model          C vs A                                                      1.39 (1.16-1.66)   0.00
  rs753955^(22)^                GG         65     13.0      65                  13.0                           
  13q12.12,*MIPEP-TNFRSF19*     GA         214    42.8      223                 44.6                           
                                AA         221    44.2      212                 42.4                           
  Multiplicative model          G vs A                                                      0.96 (0.80-1.15)   0.68
  rs6495309^(25)^               CC         160    32.0      155                 31.0                           
  15q25,CHRNA3                  CT         253    50.6      241                 48.2                           
                                TT         87     17.4      104                 20.8                           
  Multiplicative model          C vs T                                                      1.09 (0.92-1.31)   0.32
  rs3764340^(24)^               GG         1      0.2       3                   0.6                            
  *16q23,WWOX*                  GC         74     14.8      91                  18.2                           
                                CC         425    85.0      406                 81.2                           
  Multiplicative model          G vs C                                                      0.77 (0.55-1.04)   0.09
  rs17728461^(22)^              GG         27     5.4       21                  4.2                            
  22q12.2,*MTMR3-HORMAD2-LIF*   GC         164    32.8      194                 38.8                           
                                CC         309    61.8      285                 57.0                           
  Multiplicative model          G vs C                                                      0.90 (0.73-1.11)   0.33

###### 

The optimal regression model with the maximum Cox & Snell R square and Nagelkerke R square.

  Procedure   Risk factors                Cox & Snell R square   Nagelkerke R square   Percentage Correct   P-value
  ----------- --------------------------- ---------------------- --------------------- -------------------- ---------
  1           Vegetable                   0.25                   0.33                  0.73                 0.00
  2           Education                   0.31                   0.41                  0.73                 0.00
  3           Smoking                     0.35                   0.46                  0.77                 0.00
  4           Fish and shrimps            0.36                   0.48                  0.77                 0.00
  5           Meat                        0.38                   0.50                  0.78                 0.00
  6           BMI                         0.39                   0.52                  0.78                 0.00
  7           COPD                        0.40                   0.53                  0.78                 0.00
  8           rs2736100                   0.41                   0.54                  0.78                 0.00
  9           Soybean products and nuts   0.41                   0.55                  0.78                 0.01
  10          Dairy products              0.42                   0.56                  0.79                 0.00
  11          rs3764340                   0.42                   0.56                  0.79                 0.01
  12          Cooking emissions           0.43                   0.57                  0.80                 0.01

###### 

The final multivariate logistic regression model with adjusted ORs and 95% CI.

  Risk factors                           Exp (B)   95% CI^\*^   *P*-value
  -------------------------------------- --------- ------------ -----------
  Vegetable (g/day)                      0.99      0.99-0.99    0.00
  Education                                                     0.00
  Junior high school and lower           1.00      Reference    \-
  High school                            0.36      0.24-0.55    0.00
  Greater than high school               0.29      0.19-0.44    0.00
  Smoking (pack-years)                   1.03      1.02-1.04    0.00
  Fish and shrimps (g/day)               0.97      0.96-0.98    0.00
  Meat                                                          0.00
  Deficient                              1.00      Reference    \-
  Normal                                 1.51      0.98-2.32    0.06
  Over-sufficient                        4.91      2.76-8.75    0.00
  BMI (kg/m^2^)                                                 0.00
  \<18.5                                 1.00      Reference    \-
  18.5-24                                0.54      0.25-1.17    0.12
  ≥24                                    0.27      0.12-0.59    0.00
  COPD history                                                  
  Absent                                 1.00      Reference    \-
  Present                                3.67      1.59-8.44    0.00
  rs2736100                                                     
  C allele                               1.51      1.18-1.93    0.00
  Soybean products and nuts                                     0.00
  Deficient                              1.00      Reference    \-
  Normal                                 0.80      0.50-1.28    0.36
  Over-sufficient                        0.48      0.31-0.74    0.00
  Dairy products                                                
  Deficient                              1.00      Reference    \-
  Sufficient                             0.10      0.01-0.77    0.03
  rs3764340                                                     
  G allele                               1.70      1.11-2.59    0.02
  Cooking emissions (total dish-years)                          0.05
  ≤50                                    1.00      Reference    \-
  51-100                                 1.74      1.16-2.62    0.01
  101-150                                1.07      0.64-1.80    0.79
  \>150                                  2.76      1.26-6.06    0.01
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